WELCOME TO JOHNS HOPKINS HEALTH ALERTS!

This free public service from Johns Hopkins Medicine helps keep you up to date on the latest breakthroughs for the most common medical conditions which prevent healthy aging. Browse all the articles via the Health Alert Topics navigation bar on the right, or read the headlines below.


Get the latest news sent straight to your Inbox. Register now for your FREE Johns Hopkins Health Alerts. Check the boxes below for all the topics you are interested in, enter your email address, and click "Send." It's fast, easy, and FREE.   Benefits of Being A Registered User

Enter your email here: (Example: yourname@domain.com)
Please send my alerts as:

We value your privacy and will never rent your email address.Already a Member? Manage your Health Alerts


Johns Hopkins Health Alert

Meet the Charite Disk

Comments (1)

Johns Hopkins Health Alerts | Back Pain - Osteoporosis | Meet the Charite Disk

For patients with back pain, the Charite artificial disk offers some clear advantages – but also some unanswered questions.

Each year, some 200,000 people undergo spinal fusion surgery for chronic and disabling low back pain. Some back pain sufferers may be candidates for a new device, the Charité artificial disk.

The FDA approved the Charité disk for back pain in late 2004. The disk is made of a plastic core sandwiched between two metal endplates and replaces an actual disk that is removed due to disease or injury, helping to restore the natural distance between two vertebrae. There’s no question that development of the disk opens a new era in surgery for back pain. And artificial disk surgery has a clear advantage over spinal fusion with regard to preserving spinal mobility. However, the disk has its critics -- and some of their observations are sobering.

Not everyone with back pain is a potential candidate for the Charité. The FDA formally approved the disk for people who have degenerative disk disease at one level in the lumbar spine (from L4––S1) and who have experienced no back pain relief after at least six months of non-surgical treatment for low back pain. It is not recommended for people with scoliosis, spondylolisthesis, or degenerative disk disease at more than one level. Overall, of people with back pain who are potential candidates for spinal surgery, 90% would still undergo spinal fusion surgery according to current practice. This may change in the future as surgeons accumulate experience with larger numbers of back pain patients and develop a fuller understanding of the outcomes people have with the Charité disk.

One of the most contentious issues surrounding the Charité disk is the variety of results seen after surgery. The disk was first approved in Europe, and a study conducted there of 53 back pain patients came to the conclusion that, "Proof that long-term results with the disk are at least as good as fusion results is still missing.” This study, published last year, offers the longest perspective of any to date, with a follow-up of 17 years.

In contrast, a second European study of 107 back pain patients with minimum follow-up of 10 years, concluded that the outcomes seen with the disk compared favorably with those typically seen with spinal fusion surgery. In this country, the FDA based its approval on results from a study that found that back pain patients who received the disk did no worse than those who underwent spinal fusion. Follow-up in that study lasted for only 2 years.

If you believe that you’re a candidate for the artificial disk at this time, be sure to ask your surgeon plenty of questions about what your expectations, data on outcomes, and the potential for disk failure. If you want to take a wait-and-see stance, more studies on the Charité disk will be forthcoming. In addition, other artificial disks are being developed for people with back pain and tested in clinical trials, some in head-to-head comparison studies with the Charité disk.

Johns Hopkins Health Alerts | Back Pain - Osteoporosis | Meet the Charite Disk

Posted in Back Pain on September 7, 2007


Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Johns Hopkins Health Alerts Disclaimer


Notify Me

Would you like us to inform you when we post new Back Pain Health Alerts?

Post a Comment

Comments

Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.


This info was helpful for me about the Charite artif. disk, since I have many maladys of the spine, and it wasn't meant for me, but I agree it is a very good alternative for some sufferers..thx SheilLH

Posted by: SheilLH | February 5, 2011 8:37 PM

Post a Comment


Already a subscriber?

Login

Forgot your password?

New to Johns Hopkins Health Alerts?

Register to submit your comments.

(example: yourname@domain.com)

(800) 829-0422

Registered Users Log-in:

Forgot Password?

Become a Registered User!
It's fast and FREE!
The Benefits of Being a Registered User

Health Topic Pages

  • Health Alert
  • Special Report

What is this?

XML


Johns Hopkins’ Back Pain and Osteoporosis Bestsellers

Johns Hopkins White Papers

  • 2011 Back Pain and Osteoporosis White Paper
    A lifetime of walking, standing, lifting, and twisting causes significant low back pain in 80% of all adults. And as our population continues to age, osteoporosis becomes an increasingly widespread problem. In the Back Pain and Osteoporosis White Paper, Johns Hopkins experts discuss sprains, strains, spasms, disk herniation, degenerative changes in the disks and spine, spinal stenosis, and osteoporosis, a common cause of hip and spine fractures. You will explore causes of back pain, learn about preventive steps and pain relief, and examine treatments that include the latest drug and surgical options. 96 pages.
    Click here to read more or order the DIGITAL DOWNLOAD
    Click here to read more or order the PRINT EDITION


Related Titles: